|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2005-9-30
|
|
pubmed:abstractText |
Congestive heart failure (CHF) is associated with severe structural changes of atria, contributing to impaired atrial function and the risk of arrhythmia. This study investigated the effects of CHF treatments on atrial remodelling.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2193-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16141258-Aldosterone Antagonists,
pubmed-meshheading:16141258-Animals,
pubmed-meshheading:16141258-Atrial Fibrillation,
pubmed-meshheading:16141258-Cardiomyopathy, Dilated,
pubmed-meshheading:16141258-Fibrosis,
pubmed-meshheading:16141258-Heart Atria,
pubmed-meshheading:16141258-Heart Failure,
pubmed-meshheading:16141258-Male,
pubmed-meshheading:16141258-Myocardial Infarction,
pubmed-meshheading:16141258-Myocardium,
pubmed-meshheading:16141258-Rats,
pubmed-meshheading:16141258-Rats, Wistar,
pubmed-meshheading:16141258-Spironolactone,
pubmed-meshheading:16141258-Ventricular Remodeling
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.
|
|
pubmed:affiliation |
Centre de Recherches Cardiovasculaires Inserm Lariboisière--Unité U689, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
